Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 536

1.

Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms.

Brandi ML, Hukkanen M, Umeda T, Moradi-Bidhendi N, Bianchi S, Gross SS, Polak JM, MacIntyre I.

Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2954-8.

2.

Expression and functional role of nitric oxide synthase in osteoblast-like cells.

Riancho JA, Salas E, Zarrabeitia MT, Olmos JM, Amado JA, Fernández-Luna JL, González-Macías J.

J Bone Miner Res. 1995 Mar;10(3):439-46.

PMID:
7540349
3.
4.

A possible role for nitric oxide in osteoclastogenesis associated with cholesteatoma.

Jung JY, Pashia ME, Nishimoto SY, Faddis BT, Chole RA.

Otol Neurotol. 2004 Sep;25(5):661-8.

PMID:
15353992
6.
8.

Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.

Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane JR.

Br J Pharmacol. 1995 Apr;114(7):1335-42.

9.

Expression of nitric oxide synthase isoforms in bone and bone cell cultures.

Helfrich MH, Evans DE, Grabowski PS, Pollock JS, Ohshima H, Ralston SH.

J Bone Miner Res. 1997 Jul;12(7):1108-15. Erratum in: J Bone Miner Res 1997 Sep;12(9):1538.

10.

Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors.

Mitchell JA, Kohlhaas KL, Sorrentino R, Warner TD, Murad F, Vane JR.

Br J Pharmacol. 1993 May;109(1):265-70.

13.

Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.

Maciejewski JP, Selleri C, Sato T, Cho HJ, Keefer LK, Nathan CF, Young NS.

J Clin Invest. 1995 Aug;96(2):1085-92.

14.

Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures.

Galea E, Feinstein DL, Reis DJ.

Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10945-9.

15.

Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro.

Balligand JL, Ungureanu-Longrois D, Simmons WW, Pimental D, Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidoff AJ, Kelly RA, et al.

J Biol Chem. 1994 Nov 4;269(44):27580-8.

16.

Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.

Mentaverri R, Kamel S, Wattel A, Prouillet C, Sevenet N, Petit JP, Tordjmann T, Brazier M.

J Cell Biochem. 2003 Apr 15;88(6):1145-56.

PMID:
12647297
18.

Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes.

Nussler AK, Di Silvio M, Liu ZZ, Geller DA, Freeswick P, Dorko K, Bartoli F, Billiar TR.

Hepatology. 1995 Jun;21(6):1552-60.

PMID:
7539395
19.

Involvement of nitric oxide in bone marrow-derived natural suppressor activity. Its dependence on IFN-gamma.

Angulo I, Rodríguez R, García B, Medina M, Navarro J, Subiza JL.

J Immunol. 1995 Jul 1;155(1):15-26.

PMID:
7541413
20.

2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo.

Faraci WS, Nagel AA, Verdries KA, Vincent LA, Xu H, Nichols LE, Labasi JM, Salter ED, Pettipher ER.

Br J Pharmacol. 1996 Nov;119(6):1101-8.

Supplemental Content

Support Center